Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Comprehensive Loss (Unaudited)

v3.26.1
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Income Statement [Abstract]        
REVENUES $ 1,132 $ 941 $ 2,090 $ 1,662
COST OF REVENUES 553 636 1,276 1,106
GROSS PROFIT 579 305 814 556
OPERATING EXPENSES:        
Research and development expenses 658 675 1,347 1,356
Sales and marketing expenses 766 700 1,441 1,366
General and administrative expenses 737 703 1,471 1,419
TOTAL OPERATING EXPENSES 2,161 2,078 4,259 4,141
OPERATING LOSS (1,582) (1,773) (3,445) (3,585)
Interest expense (106) (22) (120) (56)
Other Financial income (expense), net 295 (106) (284) (120)
NET COMPREHENSIVE LOSS FOR THE PERIOD $ (1,393) $ (1,901) $ (3,849) $ (3,761)
Net loss per share attributable to common shareholders – basic (in Dollars per share) $ (0.05) $ (2.08) $ (0.19) $ (4.26)
Net loss per share attributable to common shareholders diluted (in Dollars per share) $ (0.05) $ (2.08) $ (0.19) $ (4.26)
Weighted average number of common stocks used in computing net loss per share – basic (in Shares) 25,814,769 914,413 20,753,201 883,744
Weighted average number of common stocks used in computing net loss per share diluted (in Shares) 25,814,769 914,413 20,753,201 883,744